Search
Jul 11
Stifel's Paul Matteis joins BiotechTV for Analyst Thursdays from Boston
He provides an in-depth discussion on this week's uniQure data, and upcoming data from Lexeo. Plus, comments on Alnylam, Dyne,...
Feb 22
Stifel's Paul Matteis covers earnings season and recent clinical data in biotech on Analyst Thursdays
Paul Matteis gives his take on biotech's start to the year and comments on Alnylam, Biogen, Vertex, KalVista, Denali, Acadia, and more.
Nov 9, 2023
Stifel's Paul Matteis joins BiotechTV for Analyst Thursdays
Paul Matteis comments on Biogen and Vertex earnings, discusses recent news on BioMarin and Sage.
.png){kind=logo}
